<< Read Full Article
<< Read Full Article
The big news this week was Takeda's $9 billion acquisition of Millennium Pharmaceuticals (MLNM Quote). The deal, or rather my perceived coverage of it, prompted a complaint from Rod R.
"So Adam, the biggest biotech rally in many months, like up 3% or better, and you have nothing to report? Maybe the hedgies are looking for virgin territory? It certainly deserves commentary. Got nothing?"
Rod, you need to subscribe to RealMoney, our subscription site! I was posting there all Thursday, discussing the Millennium takeout and the broader effect on the biotech sector. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,405.83 | 1,102.35 | 2,190.86 | 34.82 |
Oil *
71.98
|
|
UP
68.78
|
UP
6.41
|
UP
7.13
|
UP
0.59
|
10 Yr
3.48%
SPDR Gold
110.82
|
|
+0.67%
|
+0.58%
|
+0.33%
|
+1.72%
|
Data delayed 20 minutes |
Connect with TheStreet